Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ping An Biomedical CoPASW -6.49%17 EV-to-EBIT is -8.37 as of Jul. 25, 2026. GuruFocus rates PASW with a GF Score™ of 17/100. The stock has 3 warning signs investors should review. Among 804 Manufacturing - Apparel & Accessories companies, Ping An Biomedical Co ranks worse than 124377.99% on this metric.
Ping An Biomedical Co (NAS:PASW) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Ping An Biomedical Co's Enterprise Value for the quarter that ended in Sep. 2025 was $26.73 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Textile Manufacturing subindustry, Ping An Biomedical Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ping An Biomedical Co EV-to-EBIT vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Ping An Biomedical Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Ping An Biomedical Co's EV-to-EBIT falls into.
Ping An Biomedical Co's current Enterprise Value is $16.82 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ping An Biomedical Co's EBIT for the trailing twelve months (TTM) ended in Sep. 2025 was $-2.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ping An Biomedical Co (PASW) has a EV-to-EBIT of -8.37 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ping An Biomedical Co and its competitors. According to the industry distribution chart, Ping An Biomedical Co ranks #999999 out of 804 companies in the Manufacturing - Apparel & Accessories industry.
Is Ping An Biomedical Co's EV-to-EBIT too high?
Ping An Biomedical Co's current EV-to-EBIT is -8.37. Based on the distribution chart, Ping An Biomedical Co ranks #999999 out of 804 companies in the Manufacturing - Apparel & Accessories industry, which is in the bottom quartile relative to peers. Overall, Ping An Biomedical Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Ping An Biomedical Co's EV-to-EBIT compare to DXYN and CULP?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Ping An Biomedical Co ranks #999999 out of 804 companies for EV-to-EBIT. This places Ping An Biomedical Co in the lower half of its industry. The industry median EV-to-EBIT is 13.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Manufacturing - Apparel & Accessories company?
The median EV-to-EBIT among Manufacturing - Apparel & Accessories companies is 13.30, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Ping An Biomedical Co and its competitors. For the Manufacturing - Apparel & Accessories industry, the median EV-to-EBIT is 13.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ping An Biomedical Co's current EV-to-EBIT is -8.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ping An Biomedical Co stock overvalued right now?
Ping An Biomedical Co (PASW) has a current EV-to-EBIT of -8.37. The current EV-to-EBIT is -8.37. Ping An Biomedical Co's overall GF Score™ is 17/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Ping An Biomedical Co (PASW), the current EV-to-EBIT is -8.37 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand. The group is a provider of SCM services in the apparel industry, offering solutions for a broad range of yarn products, textiles, and finished garments. Its service offerings encompass every key aspect of the supply chain of textile products, such as market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. The group has two reportable segments, yarns and finished garments. The majority of its revenue is generated from the sale of yarns, including pure cashmere and cashmere-mix yarn, merino wool, cotton, and fancy yarn.
17GF Score
Get the complete analysis for PASW
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PASW has been successfully added to your 
